Stay updated on Emapalumab Clinical Trial in MAS/sHLH
Sign up to get notified when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.

Latest updates to the Emapalumab Clinical Trial in MAS/sHLH page
- Check4 days agoChange DetectedAdded a dedicated Locations section including Ohio, updating where the study is conducted. Removed the HHS Vulnerability Disclosure footer link and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedTwo minor text updates were made: the Publications note now states that items are automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoval of the government funding status banner from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedCore study information appears unchanged between the screenshots; only minor formatting or layout adjustments are visible.SummaryDifference0.4%

- Check83 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check90 days agoChange DetectedThe page adds the capitalized term “Adult-onset Still disease” and updates the revision to v3.1.0, replacing the previous “Adult-onset still disease” and v3.0.2.SummaryDifference0.2%

Stay in the know with updates to Emapalumab Clinical Trial in MAS/sHLH
Enter your email address, and we'll notify you when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.